ORMP — Oramed Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00
- $91.98m
- -$19.98m
- $1.34m
- 48
- 33
- 83
- 55
2019 August 31st | 2020 August 31st | 2021 August 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 32.3 | 39.9 | 94.1 | 156 | 162 |
Prepaid Expenses | |||||
Total Current Assets | 33.3 | 40.5 | 95.3 | 157 | 163 |
Net Property, Plant And Equipment | 0.024 | 0.174 | 0.93 | 1.8 | 1.57 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 34.7 | 44.6 | 128 | 162 | 221 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 5.31 | 4.54 | 6.68 | 5.75 | 53.2 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 15.3 | 11.8 | 12.2 | 9.83 | 56.7 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 19.4 | 32.9 | 116 | 152 | 164 |
Total Liabilities & Shareholders' Equity | 34.7 | 44.6 | 128 | 162 | 221 |
Total Common Shares Outstanding |